News

ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...
The Global Intraocular Lens Market valued at US $3.9 billion in 2021 and is set to witness a growth rate of ~5-6% in the next 5 years. The global growth in cataract procedures driven by an aging ...
In April 2025, Berkeley Eye Center conducted a study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, ...
Alcon ALC recently received Food and Drug Administration (“FDA”) approval for its TRYPTYR (acoltremon ophthalmic solution) 0.003%. TRYPTYR is indicated for the treatment of the signs and symptoms of ...
Alcon also has a suite of advanced-technology intraocular lenses, or ATIOLs, that go beyond correcting vision issues at one distance. Although today’s global ATIOL market penetration rate by ...
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS ...
Alcon Inc (ALC) reports a 3% revenue increase and strategic initiatives to counter market softness and tariff impacts.
Breakthrough instruments like optical coherence tomography (OCT) and affordable intraocular lenses (IOLs) broaden the availability of cutting-edge ophthalmic care, enhancing early detection and ...